The University of Texas Health Science Center at San Antonio  (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]

  Lei Zheng, MD, PhD, alumnus of The University of Texas Health Science Center at San Antonio (UT Health San Antonio), has been appointed executive director of Mays Cancer Center at UT Health San Antonio and vice president for oncology for the health science center, effective Sept. 1, 2024. Zheng will also be named the Mays Family Foundation Distinguished […]

  As part of the $52 million Cancer Prevention and Research Institute of Texas (CPRIT) grant funding round announced in May, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a $2 million CPRIT recruitment (CPRIT Scholar) funding award to bring top cancer researcher, Maria Falzone, PhD, to the […]

Mays Cancer Center offers a survivorship program to patients to prevent cancer from reoccurring through interventions and surveillance to help them live well after treatment.

Learn about Mays Cancer Center’s cardio-oncology program and what cancer patients who have cardiovascular conditions can expect.

Kate Lathrop, MD, shares how participating in a clinical trial can play a key role in an expansion of your care team and survivorship.

Listen to one expert highlight the benefits of having a cancer rehabilitation program that focuses on preventing long-term complications that may come from symptoms or side effects related to cancer treatment.

Executive Director Ruben Mesa, MD, explains the benefits of having access to clinical trials and the cutting-edge capabilities they provide for patients in South Texas.

Mark Bonnen, MD, discusses how Mays Cancer Center’s Medical Management Program integrates primary care into cancer care to better support our patients.

Kate Lathrop, MD, explains the advantages of being able to collaborate as an NCI- designated Cancer Center and produce translational research to improve patient care.